Study to Assess Efficacy and Safety of XC221 in the Treatment of Influenza and Other Acute Respiratory Viral Infections
Clinical trial NCT03455491 · COMPLETED
Trial details
- NCT number
- NCT03455491
- Sponsor
- PHARMENTERPRISES LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-12
- Primary completion
- 2018-06-28
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.